LivaNova PLC
LIVN
Κατάταξη σε μετοχές
#3706
LivaNova PLC is a global medical technology company dedicated to developing,... LivaNova PLC is a global medical technology company dedicated to developing, manufacturing, and marketing a variety of therapeutic solutions. The company operates through three key segments. Its Cardiopulmonary division provides essential products for heart-lung procedures, such as oxygenators, heart-lung machines, and various perfusion systems. The Neuromodulation segment is known for its VNS Therapy System, an implantable device that delivers vagus nerve stimulation to treat drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. This segment is also advancing the VITARIA System, which employs VNS for heart failure, through clinical development. The Advanced Circulatory Support segment offers temporary life support solutions, including both cardiopulmonary and respiratory support technologies. LivaNova serves a wide range of medical professionals, including perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals and healthcare providers. The company's products are distributed globally through both its direct sales force and independent distributors. Additionally, LivaNova has a research collaboration with Verily aimed at discovering clinical biomarkers for depression. Founded in 1987, the company is headquartered in London, United Kingdom.
Τιμή μετοχής
$81.22
Κεφαλαιοποίηση
$4.46B
Αλλαγή (1 ημέρα)
3.54%
Αλλαγή (1 έτος)
48.07%
Χώρα
GB
Εμπόριο LivaNova PLC (LIVN)
Κατηγορία
Healthcare
Ιστορικό τιμής μετοχής για την LivaNova PLC (LIVN)
Υψηλότερη τιμή κλεισίματος: $77.04 στις 2026-10-01
Χαμηλότερη τιμή κλεισίματος: $65.54 στις 2015-10-01
Χαμηλότερη τιμή κλεισίματος: $65.54 στις 2015-10-01
Ιστορικό τιμής μετοχής της LivaNova PLC από 2015 έως 2026
Ετήσια απόδοση τιμής μετοχής
| Έτος | Απόδοση |
|---|---|
| 2026 (TTM) | 10.24% |
| 2025 | 28.07% |
| 2024 | 0.72% |
| 2023 | -10.64% |
| 2022 | -34.07% |
| 2021 | 32.23% |
| 2020 | -19.53% |
| 2019 | -16.15% |
| 2018 | 13.93% |
| 2017 | 79.34% |
| 2016 | -22.00% |
| 2015 | 0.00% |
Τιμή μετοχής για παρόμοιες εταιρείες ή ανταγωνιστές
| Εταιρεία | Τιμή μετοχής | Μεταβολή 1Έτ% | Χώρα |
|---|---|---|---|
| $102.65 | -19.77% |
US
|
|
| $96.45 | 0.57% |
IE
|
|
| $307.12 | -20.92% |
US
|
|
| $46.02 | -55.69% |
US
|
|
| $47.05 | -17.88% |
DE
|
